ArticleBrain communications2026
Incomplete T-cell tolerance and epitope-specific responses to the NR1 subunit in NMDA receptor antibody-associated encephalitis.
Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
NMDA receptor antibody-associated (NMDAR-Ab) encephalitis primarily affects young women and children and often requires prolonged intensive care admission. Currently available first- and second-line therapies are effective, but patients can be refractory and residual deficits are not uncommon. Although B-cell lineages and specific NMDAR (NR1 subunit) antibodies have been examined in detail, the subtypes and roles of antigen-specific T cells in providing T-cell help to drive the IgG antibody response, cytotoxic effects or other roles have not been reported. Peripheral blood mononuclear cells from eight patients and eight healthy volunteers underwent three rounds of stimulation with pooled 15-mer peptides spanning the length of the NR1 sequence. At each round of stimulation, functional CD4+ and CD8+ T-cell responses to NR1-derived peptide pools were assessed using flow cytometry. CD4+ and CD8+ T responses to NR1-derived peptide pools were identified in both patients and healthy volunteers. Patient CD4+ T-cell responses were more frequent compared to healthy volunteers after the first round of stimulation, with fewer responses after the third round. Healthy volunteer CD4+ T cells showed the opposite trend (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.